Post by PressRelease on May 09, 2024 7:00am
New Press Release - Oncolytics Biotech® Receives Regulatory Clearance to Evaluate Pelareorep in Combination with Modified FOLFIRINOX +/- an anti-PD-L1 Inhibitor in Pancreatic Cancer
Comment by
Noteable on May 09, 2024 8:57am
Since ONCY is moving into a registration study in the orphan/rare disease of pancreatic cancer, ONCY's is on the doorstep of an Accelerated Approval for this indication. ONCY just has to step up and request the Accelerated Approval from the FDA, which could be what the requested Type C meeting with the FDA is partially about.
Comment by
ENEMENEMYNEMO on May 09, 2024 9:04am
Hey Mr Note Pumper, This is not a registrational study, you've got to wait 3+ yrs for that. ""If the mFOLFIRINOX combination shows a compelling efficacy signal, this therapeutic approach could also be advanced to a registration-enabling study, providing two opportunities for pelareorep-based treatment to benefit pancreatic cancer patients,"
Comment by
ENEMENEMYNEMO on May 09, 2024 9:07am
This will however give Matt the opportunity to dilute the sp with further offerings though!
Comment by
Azzak34 on May 09, 2024 9:09am
Oof Nemo must need a few extra quid this week, working hard this morning!! This is a completely new opportunity. Panc and Breast are still carrying on. You have no idea what you're doing here do you?
Comment by
ENEMENEMYNEMO on May 09, 2024 9:17am
Nah just a day off and it's raining. Wait somebody will pay me for this??
Comment by
ENEMENEMYNEMO on May 09, 2024 9:19am
I guess the proofs in the puddin'. Let's see where the sp is tomorrow?
Comment by
Azzak34 on May 09, 2024 9:20am
Yeah you get paid per post and they couldn't care less about spelling or general grammar. See if Bucky can hook you up.
Comment by
ENEMENEMYNEMO on May 09, 2024 9:33am
You are such a dryshite ...are you Canfan?? Cus he certainly has not been posting ad nauseam as per past experience.
Comment by
Azzak34 on May 09, 2024 10:03am
Haha don't get upset babe, just get better. He's a 2/3 per week type of poster. I'm more reactive.
Comment by
Noteable on May 09, 2024 9:07am
It's apparent that some who post here can't understand what's written regarding ONC's Phase 3 registration studiy in pancreatic cancer and the Accelerated Approval implementation.